V ertebral compression fractures (VCFs) constitute a major health care problem, not only because of their high incidence but also due to both direct and indirect consequences of VCFs on health-related quality of life and health care expenditures. [1] [2] [3] Approximately 26% of women over 50 years old and 40% of women over 80 years old are reported to have sustained a VCF. [4, 5] However, only one-third to three-quarters of such patients then develop chronic back pain, [1] which may be attributed to pseudarthrosis or to osteoporotic spinal deformities such as kyphosis or kyphoscoliosis. The degree of kyphosis correlates well with the patient's physical function, risk of further fractures, [6, 7] compression of the spinal cord, mental well-being, and pulmonary function, [8] any of which may contribute to an increased mortality rate. [7, 9, 10] Regardless of their etiology, the mainstay of management for symptomatic VCFs is targeted medical therapy, including analgesics, bed rest, external fixation, and rehabilitation. [11, 12] However, anti-inflammatory drugs and certain types of analgesics can be poorly tolerated by elderly patients, and bed rest may lead to further demineralization, predisposing the patient to future fractures. Moreover, because of the poor quality of osteoporotic bone, surgical fixation often fails. [13] Further, because of the risks of open surgery in elderly patients suffering from VCF, surgical procedures have generally been limited to cases where there is concurrent spinal instability or neurologic deficits. [8, 9] Balloon kyphoplasty and vertebroplasty are two minimally invasive, percutaneous surgical approaches that have recently been developed for the management of symptomatic VCFs. [14, 15] Vertebroplasty involves percutaneous injection of viscous polymethylmethacrylate (PMMA) into the vertebral body and was first described by Galibert et al. in 1987 . [16] In balloon kyphoplasty, a tamp (balloon) is inserted into the vertebral body using either a transpe-dicular or extrapedicular route, leading to compression of cancellous bone, creation of a cavity, and if possible, realignment of the endplate of the vertebral body, and PMMA is then injected. After removal of the bone tamp, the injected PMMA fixes and stabilizes the fracture. Although there have been numerous studies investigating the efficacy of vertebroplasty and kyphoplasty for the treatment of VCF, much of the literature is from retrospective studies or case series.
The purpose of this study was to perform a comprehensive review of the literature and conduct a meta-analysis to compare clinical outcomes of pain relief and function, radiographic outcomes of the restoration of anterior vertebral height (AVH) and kyphotic angles, and subsequent complications associated with these two techniques.
Literature search
A number of bibliographic databases were searched, including PubMed, Medline, ACP Journal Club, DARE, CCTR, CDSR, and the Cochrane Library. Searches were conducted using the terms "vertebroplasty" or "kyphoplasty" and the results were restricted to reports that were published from April 1998 to March 2011. Abstracts were reviewed, and studies containing information on pain relief or complications after vertebroplasty or kyphoplasty were saved for further review.
From this literature, data on preoperative visual analog scale (VAS), postoperative VAS, changes in VAS, and functional scores such as the Oswestry Disability Index and Short Form 36 were collected. Any complications related to either vertebroplasty or kyphoplasty were also identified. Demographic data were also collected, including the sample size, gender, mean age, diagnoses, number of levels treated, and length of follow-up. Moreover, because of the large number of case series available in the literature, only systematic reviews and controlled studies were included.
Statistical analyses
Pooled preoperative and postoperative VAS data were analyzed using paired t tests to determine whether any significant differences existed for the combined population. Changes in VAS scores and functional scores were also compared using standard t tests to determine whether there were significant differences in the degree of postoperative changes following vertebroplasty and kyphoplasty. Studies that reported associated complications were identified, and the overall complication rate was calculated by examining the occurrence of complications in relation to the total number of procedures and patients in each series. A Chi-square analysis was performed to identify any significant differences in the rate of cement leak, pulmonary embolism, neurological complication, or new fracture after vertebroplasty versus kyphoplasty. However, if the total number of procedures performed or number of patients treated was not reported in the case reports, these cases were not included in the risk analysis.
Surgical technique
Percutaneous vertebroplasty has been thoroughly described in previous studies. [17] The general methodology used for kyphoplasty is described below. Percutaneous kyphoplasty is performed under local anesthesia with patients in the prone position. Preoperative prophylactic first-generation cephalosporin is administered to each patient, and fluoroscopy is used throughout the procedure. An incision is made on the pedicle level of the skin, and the correct incision site is identified using the anteroposterior (AP) view of the image intensifier. An inflatable balloon is then inserted unilaterally into the fractured vertebral body, and a needle pipe and pin are placed via the incision, with the tip placed lateral to the pedicle projection in the AP view and parallel to the superior endplate in the lateral view [ Figure 1 ]. The needle pin is then removed, and the wire pin is introduced into two-thirds of the vertebral body. The needle pipe is subsequently removed, and a cannular and expander are inserted into the pedicle through the wire pin [ Figure 2 ]. After removal of the wire pin and insertion of the drill, the balloon is slowly inflated [ Figure 3 ]. The volume of the balloon is controlled in order to recover the damaged vertebral body until adequate kyphotic angle reduction is obtained or the inflation pressure reaches 220 psi. The amount of injected fluid can be used to predict the cement volume [ Figure 4 ]. Thereafter, the balloon is deflated and withdrawn, and the resulting intravertebral cavity is filled with PMMA cement [ Figure 5 ].
Selection of studies
A total of 791 citations related to either vertebroplasty or kyphoplasty were identified. All studies that used additional instrumentation, compared the results with conservative treatment, used non-PMMA augmentation, had VCFs related to metastatic compression fractures, or were not available in full-text format were excluded. Of the remaining 187 citations, case series, review articles, publications describing novel basic technologies, and technique reports were eliminated. The remaining 14 studies, including 7 systematic reviews [18] [19] [20] [21] [22] [23] [24] and 7 controlled studies, [25] [26] [27] [28] [29] [30] [31] were saved and reviewed. The selection process is described in Figure 6 .
Demographic data
From the seven systematic review studies, the results of 336 subjects, including 45 patients from prospective studies and 291 patients from retrospective studies conducted between 1996 and 2007, were presented, with follow-up ranging from 1 to 5 years [ Table 1 ]. Of the seven controlled studies, four were prospective and three were retrospective, including 393 patients with a mean age of 76 years (range, 58-92) who underwent 194 kyphoplasties and 199 vertebroplasties [ Table 2 ].
Outcomes: Pain and functional improvement
Within the seven systematic reviews, specific data A total of 791 citations related to either vertebroplasty or kyphoplasty were identified. The remaining 14 studies, including 7 systematic reviews and 7 controlled studies, were saved and reviewed. The selection process is described.
for VAS scores after kyphoplasty and vertebroplasty were identified for 336 subjects. [18] [19] [20] [21] [22] [23] [24] Mean improvements in VAS scores ranged from 3.6 to 5.6 in the kyphoplasty group and from 2.6 to 5.6 in the vertebroplasty group. There was no statistically significant difference between the two groups in terms of pain improvement (p > 0.01) [ Figure 7 ]. One-day [ Figure 8 ] and 1-year [ Figure 9 ] pain improvement in the seven controlled studies were also not statistically significant. Functional outcomes in the three retrospective controlled studies were not statistically significant at either the 1-day [ Figure 10 ] or 1-year [ Figure 11 ] follow-up.
Radiographic outcomes
AVH restoration in the four prospective controlled studies ranged from 6.5% to 33.0% in the kyphoplasty group and from 0% to 13.7% in the vertebroplasty group. There was a statistically greater improvement in AVH restoration after kyphoplasty than in AVH restoration after vertebroplasty (p < 0.05) in one study [ Figure 12 ].
Kyphotic angle restoration in the four prospective controlled studies ranged from 6° to 7.9° in the kyphoplasty group and from 0° to 4.6° in the vertebroplasty group. There was a statistically greater improvement in kyphotic angle correction after kyphoplasty than in kyphotic angle correction after vertebroplasty (p < 0.001) in two studies [ Figure 13 ].
Complications
The literature search identified five systematic reviews and seven controlled studies that described the occurrence of cement leakage after vertebroplasty or kyphoplasty. Moreover, five systematic reviews described the occurrence of new fractures. Cement leakage out of the vertebral body occurred in 0-15% of patients after kyphoplasty and 0.3-41% of patients after vertebroplasty [ Figure 14 ]. Pulmonary embolisms caused by cement leakage occurred in 0-1.2% of patients following kyphoplasty and 0.17-11% of patients after vertebroplasty [ Figure 15 ], and neurological complications resulting from cement leakage occurred in 0-2.9% of patients after kyphoplasty and 0.03-23% of patients after vertebroplasty [ Figure 16 ]. The prevalence of new compression fractures was 9-37% after kyphoplasty and 10-52% after vertebroplasty [ Figure 17 ].
Discussion
Vertebroplasty and kyphoplasty are well-established techniques that have been reported to provide significant relief to patients with painful VCFs related to osteoporosis, multiple myeloma, hemangioma, and metastases. [16] Unfortunately, much of the current literature investigating vertebroplasty and kyphoplasty consists of retrospective cases series and case reports. Moreover, few studies have directly compared vertebroplasty and kyphoplasty. The purpose of this study was to perform a comprehensive review of the literature to determine the effectiveness of vertebroplasty and kyphoplasty in treating symptomatic VCFs and to assess the risk of complications associated with these two common techniques.
Clinical outcomes
The combined data revealed that both vertebroplasty and kyphoplasty were effective in reducing pain and improving functional outcomes. Statistically significant improvements were achieved after both techniques, and mean improvements in VAS scores for both vertebroplasty and kyphoplasty exceeded 33% change, which has been reported to be a reasonable standard for meaningful change. [32] Complications Vertebroplasty compared with kyphoplasty was found to be associated with a significantly greater risk of cement leak, which resulted in a relatively higher risk of pulmonary embolism and neurological complications such as myelopathy or radiculopathy. It has been suggested that this difference is reflective of the creation of the cavity and the use of more viscous cement in balloon kyphoplasty. [33] [34] [35] With vertebroplasty, the cement must be able to fill the gaps between fracture fragments and thus must be less viscous, allowing it to more easily leak through defects in the cortex. Additionally, it is believed that the impaction of the trabecular bone against the surrounding cortical bone reduces the risk of cement penetrating the cortex. Another factor related to the leakage of cement in both vertebroplasty and kyphoplasty is the fracture pattern. Disruption of the endplates and anterior or posterior wall fractures can increase the risk of cement leaks. In the studies reviewed here, the majority of leaks were asymptomatic, incidental findings; however, these leaks can lead to both minor and major complications. Patients may develop transient radicular pain after a cement leak into the foramen or spinal canal. Furthermore, larger cement volumes have the potential to cause spinal cord compression and paralysis. Many patients with these cement leaks need to return to the operating room for emergent decompression and stabilization. [36] [37] [38] [39] [40] [41] 
New fractures
Pooling the results of the five systematic reviews reporting incident vertebral fractures revealed a significant reduction in the incidence of new fractures with balloon kyphoplasty compared with vertebroplasty. This may have resulted from the decreased occurrence of cement leakage into the vertebral discs and the better sagittal alignment achieved by kyphoplasty. [42, 43] In studies of vertebroplasties, intradiscal cement leakage had an odds ratio of 4.633. [42] Other variables, including age, gender, bone mineral density, number of procedures, number of vertebrae treated, amount of cement injected, and cement leakage into the soft tissues or veins, did not increase the risk of new VCFs. Prior studies have reported that patients who have had a VCF have a fourfold higher risk of experiencing an additional VCF than patients who have not had a VCF. [44] This supports the argument that there is an increased risk of developing additional VCFs after vertebroplasty than in patients with osteoporosis. This finding is in contrast to two recently published studies suggesting that a greater level of complications occurs after balloon kyphoplasty than after vertebroplasty [45] and that there is an increased incidence of VCFs following balloon kyphoplasty relative to patients with no history of fractures. [46] However, the findings of these two studies must be interpreted within the context of all available evidence, and they have both received considerable criticism on the basis of their poor methodology. [47, 48] Cost-effectiveness Ström et al. in 2010 developed a Markov cost-effectiveness model to estimate the cost-effectiveness of balloon kyphoplasty compared with non-surgical management in a UK setting. [49] The procedure was associated with quality-adjusted life-years (QALY)-gains of 0.17 and cost/ QALY-gains at ≤ 8800. The results were sensitive to assumptions about avoided length of hospital stay and persistence of kyphoplasty-related quality of life benefits. In 2012, a Markov simulation model was developed to evaluate treatment with balloon kyphoplasty, non-surgical management, and percutaneous vertebroplasty in patients with symptomatic osteoporotic VCFs. [50] The incremental cost-effectiveness ratio of kyphoplasty was estimated at Great Britain Pound Sterling (GBP) 2706 per QALY and GBP 15,982 per QALY compared to non-surgical management and vertebroplasty, respectively. In conclusion, the results indicate that kyphoplasty provides a cost-effective alternative for treating patients with hospitalized VCFs in a UK-setting.
Strengths and limitations
The principal strength of this review is its comprehensiveness. We undertook exhaustive searches of the literature and sought all published and unpublished evidence. Inevitably, any review can be subject to publication bias, i.e. studies with "positive" results are more likely to be reported and published, while side effects and adverse events are more likely to be underreported.
The principal limitation in the interpretation of the findings of this review was the absence of prospective randomized controlled trial (or "level I") evidence. However, it is important to point out that although case series studies are relatively low in the hierarchy of evidence, well-conducted and adequately reported studies can provide useful data on the "real world" effectiveness and safety of the procedure. Furthermore, as discussed above, this review has identified a growing number of direct, albeit non-randomized, comparative studies. It is recognized that because of non-random allocation of patients to intervention and control, studies are prone to substantial selection bias and confounding.
Conclusions
Both percutaneous vertebroplasty and balloon kyphoplasty have been shown to be effective in controlling pain and improving function. Kyphoplasty not only has the advantage of improving or restoring vertebral height and kyphotic deformities, but can also decrease cement leakage and reduce the occurrence of new fracture. Although there was a good ratio of benefit to harm for both procedures, balloon kyphoplasty appears to have a less short-term adverse event in cement leakage and new fractures. Effectiveness and safety between the two procedures require confirmation by more prospective, randomized, controlled trials.
